Domus Search - The European BioTech, Pharma & MedTech C-Suite Leadership Podcast

Domus Search - The European BioTech, Pharma & MedTech C-Suite Leadership Podcast

By Matt Grady - PartnerBusinessCareers
Download on the App Store

Domus Search - The European BioTech, Pharma & MedTech C-Suite Leadership Podcast episodes

  • Episode 10 - Dax Grant - CEO - Global Transform

    It was great to sit down in conversation with Global Transform Chief Executive Officer and Globally Recognised CIO, Dax Grant, to record an ‘Industry Expert’ video podcast on the Domus Search - Leadership Podcast.


    The Domus Search - Leadership Podcast offers a glimpse into the world of industry leaders through interactive conversations with CEO's, C-Suite Executives and Executive Leadership Teams across European BioTech and MedTech sectors.

    Domus Search is THE ONLY BioTech and MedTech Executive Search Firm with over 97% coverage of C-Suite Candidates in 45 European Countries (at any given time), and we are committed to sharing leadership insight with our European BioTech and MedTech network.

    About my guest.

    Dax has held a prominent Executive positions as CIO and Senior Executive in a number of recognisable brands such as HSBC, where Dax was CIO of Global Operations, Executive Director in Macmillan Cancer Support and MD of both Barclays and Santander UK as well as holding a Senior Director post in Visa and Barclaycard.

    What Dax doesn’t know about Digital Transformation and Advances in Technology isn’t worth knowing!!

    Dax was educated at The University of Manchester (Institute of Science & Technology) in addition to University of Cambridge and further Executive Education at Cranfield School of Management to complete her MBA and Harvard Business School for advances in her Executive Education.

    ‘Dax has real-life ‘know-how’ to digitise businesses, catalyse performance and utilise technology to unlock value.

    More about Global Transform

    Global Transform helps global and international businesses attain top quartile performance, societal impact and staff advocacy impacting the world in a positive way for shareholders. regulators and society though purpose beyond profit values. 

    Global Transform is regarded as a 'go to’ organisation that enables international and global firms to reimagine their business models, unlocking the technology advantage and empowering the boardroom.

    39 min
  • Episode 9 - Claude Kaplan - CEO - Kuehnle AgroSystems (KAS)

    I'm delighted to share today's conversation with Kuehnle AgroSystems Inc. Chief Executive Officer Claude Kaplan, on the Domus Search - Leadership Podcast.


    The Domus Search - Leadership Podcast offers a glimpse into the world of industry leaders through interactive conversations with CEO's, C-Suite Executives and Executive Leadership Teams across European BioPharma and MedTech sectors.

    Domus Search is THE ONLY BioPharma and MedTech Executive Search Firm with over 97% coverage of C-Suite Candidates in 45 European Countries (at any given time), and we are committed to sharing leadership insight with our European BioPharma and Medtech network.

    About my guest.

    Claude is a PhD in Biochemistry and Molecular Biology from the University of Cambridge which followed his MA in Natural Science (Biochemistry) from the same University.

    Claude developed his succesful career working with industry leaders such as Unilever and working with UK Trade & Investment (UKTI) to increase investment in life science based R&D in the UK before joining Hatch Blue in various leadership roles before taking on the role of Chief Executive Officer in one of Hatch Blue's portfolio organisations - Kuehnle AgroSystems Inc.

    More about Kuehnle AgroSystems Inc. (KAS)

    KAS is a Hawaii biotechnology company with a world-class team of professionals. They research, develop and produce specialty chemicals and raw materials to make life better.

    Their customers include multinational corporations along with valued regional companies and brands that require sustainable plant-based ingredients for aqua feeds, food, and personal care.

    Find out more about KAS here: https://www.kuehnleagro.com/

    Partner with KAS here: https://www.kuehnleagro.com/

    Connect with Claude here: https://www.linkedin.com/in/claudekaplan/

    35 min
  • Episode 8 - Dr Jakub Šimeček - CEO & Co-Founder - Trimt

    I'm delighted to share that I sat down in conversation with TRIMT GmbH Co-Founder & Chief Executive Officer Jakub Šimeček, to record a video podcast on the Domus Search - Leadership Podcast this morning.


    The Domus Search - Leadership Podcast offers a glimpse into the world of industry leaders through interactive conversations with CEO's, C-Suite Executives and Executive Leadership Teams across European BioTech, Pharma and MedTech sectors.

    Domus Search is THE ONLY BioTech and MedTech Executive Search Firm with over 97% coverage of C-Suite Candidates in 45 European Countries (at any given time), and we are committed to sharing leadership insight with our European BioTech and Medtech network.

    About my guest:

    Jakub´s background in chemistry with the Charles University in Prague, radiopharmaceutical sciences (as visiting researcher at University of Helsinki and at Memorial Sloan Kettering Cancer Center, NY) and the development of targeted radiolabelled conjugates, their preclinical evaluation and transfer to first-in-human studies (doctoral degree at Technical University of Munich) resulted in different positions in the radiopharmaceutical industry after leaving the academia.

    He has led various technical (small scale GMP production) and radiopharmaceutical projects toward establishing novel radiodiagnostic and radiotherapeutic applications (innovative Ga-68, Lu-177 and Ac-225 based APIs).

    Learn more about TRIMT here - https://trimt.de/

    30 min
  • Episode 7 - Leigh Fell - CEO & Founder - Caritas Neuro Solutions

    Delighted to sit down in conversation with Caritas Neuro Solutions Founder & Chief Executive Officer Leigh Fell, to record a video podcast on the Domus Search - Leadership Podcast.

    The Domus Search - Leadership Podcast offers a glimpse into the world of industry leaders through interactive conversations with CEO's, C-Suite Executives and Executive Leadership Teams across European BioPharma and MedTech sectors.

    Domus Search is THE ONLY BioPharma and MedTech Executive Search Firm with over 97% coverage of C-Suite Candidates in 45 European Countries (at any given time), and we are committed to sharing leadership insight with our European BioPharma and Medtech network.

    About my guest.

    Leigh is a graduate from the University of Glasgow and has since gone on to develop her career as a leading figure in clinical trials and research within both private and public sectors such as Clintech - an IQVIA company, and NHS National Services Scotland, before taking on NED roles and later Founding Caritas Neuro Solutions.

    Leigh’s passion for bringing a patient centred approach to clinical trials is positively infectious and she lives and breathes the values of her growing and ambitious organisation.

    More about Caritas Neuro Solutions

    With values of Compassion, Collaboration and Integrity, Caritas Neuro Solutions Mission is to improve how we do healthcare, by making clinical trials more person-centred.

    Caritas Neuro Solutions offer expertise in Project and Clinical Trial Management, Psychoactive and Classified Products, Mental Health Centred Trials, Neurology, Social Impact, Global Regulatory Affairs, Mental Health Research and initiatives to Uplift Mental Health & Well-Being.

    Leigh and her team of experts also developed a unique solution to their clients in Caritas Cohesion.  A proprietary blend of science and compassion, bringing pharmaceutical level expertise into socio-beneficial outcomes.

    Find out more about Leigh and Caritas Neuro Solutions here:

    https://caritasneuro.com/

    https://www.linkedin.com/in/leigh-fell-76228959/



    37 min
  • Episode 6 - Dr Ali Tinazli - CEO - Lifespin

    On this show, I'm delighted to sit down in conversation with Lifespin CEO Dr Ali Tinazli based in Germany, to record a video podcastfor the Domus Search Leadership Podcast.


    Domus Search is committed to sharing leadership insight to our network. The podcast offers a glimpse into the world of industry leaders through interactive conversations with CEO's, C-Suite Executives and Executive Leadership Teams across European BioPharma and MedTech sectors.

    About my guest.

    Dr Ali Tinazli completed his MSc in Biochemistry, Biophysics and Molecular Biology and went on to achieve his PhD in Nanotechnology from Goethe University, Germany. He went on to complete Executive Education with Massachusetts Institute of Technology, MIT Professional Education and Univesity of California, Berkeley, Haas School of Business.

    Since completing his PhD, Ali has gone on to take leadership roles in many household names such as Sony and HP, where he led the global strategy governing the company’s initiatives in Healthcare and Life Sciences, with a focus on Point of Care and Digital Health

    Ali sits on the Board of Softhread, a a blockchain and AI-enabled platform to build enterprise solutions and Fluxergy, a Point of Care Health Diagnostic Solutions based in California. He is also a member of the Forbes Technology Council

    As CEO of lLifespin, amongst many other responsibilities, Ali is charged with the leadership and growth of Lifespin into new regions, developing strategic partnerships and putting Lifespin on the map. His global expertise and subject matter expertise positions Ali  at the intersection of consumer technologies and healthcare, commercialising technology in Life Sciences and in vitro diagnostics. 

    About Lifespin.

    The Lifespin platform combines biology, deep data, artificial intelligence and cloud technologies to enable digital metabolic insights for Precision diagnostics, Personalised Disease management, Precision Drug Monitoring for Pharma, Research and much more.

    Lifespin is building a proprietary database, already consisting of more than 150k individual human metabolic profiles, to create a digital atlas of human health that provides deeper clinical insights based on metabolic information.

    The first commercial product in the regulated space will be software algorithms for health testing this year as a laboratory-developed test for clinical evaluation of Multiple Sclerosis followed by a test for Parkinson’s Disease diagnosis in 2023. The clinical findings to date using lifespin’s technology platform in a research-use-only context are highly promising.


    Connect with Dr Ali.

    https://lifespin.health

    https://www.linkedin.com/in/dralitinazli/

    Keep in touch with Lifespin & Dr Ali at industry events

    https://lifespin.health/newsroom/


    34 min
  • Episode 5 - Jean-Pierre (JP) De Villiers - CEO & High Performance Coach - JPDV

    JP is an inspiration to me. Ever since reading about him in Daniel Priestley's books Key Person of Influence and Oversubscribed, I have been obsessed by putting his strategies in place.

    JP is a prolific author on high-performance in life and business. Coach to C-Suite Executives, Actors, Award-Winning Film Directors, Olympic Gold Medalists (and those aspiring to be), Entrepreneurs, Founders and Teams who are looking to attain high-performance in various aspects of life and business.

    He is a regular feature in the media and has manay great talks including Tedx. Author of several books, a professional martial artist and he has completed multiple ultra-marathons amongst other endurance events.  He is an Ironman triathlete and was voted as health coach of the year.

    Drawing from personal experience, he has carved his name in stone (in my opinion), as one of the world's leading high-performance coaches.


    36 min
  • Episode 4 - Patrick Michaels - Managing Director - AKA West Palm

    On today's episode, I am joined by Founder & CEO of R3PRESENT, Patrick Michaels.

    Patrick is a leader in global sales and marketing and has operated across the globe. Building his career from the ground up, he was able to progress to the role of Managing Director and Global VP of Sales. Patrick established R3PRESENT in November 2020 in the midst of a pandemic, and continues to act as a trusted partner and extension of his client's organisation to help them realise sales potential, brand visibility and build international collaborations to enhance their service offering.

    As part of the evolution and continued development of Domus Search, it is important for us to build strong partnerships and networks with talented individuals. This approach allows us to gain an outside, and objective perspective, on what we do, and also enhances our international network of talent for our Executive Search Clients.

    To reach Patrick, you can connect directly here to LinkedIn: https://www.linkedin.com/in/patrickmichaels/ or go direct to: www.r3present.com

    40 min
  • Episode 3 - Christina Colmer McHugh - Co-Founder & Director - MOODBEAM

    On today's episode, I'm delighted to be joined by Christina Colmer McHugh, the Co-Founder and Director of the multi award winning, Moodbeam.

    www.moodbeam.co.uk 

    Moodbeam is a revolutionary, wearable healthcare technology, that is helping individuals and organisations improve their performance through instant and open feedback. Facilitating conversations, improving engagement and identifying areas for improved wellbeing and overall happiness, in and out of the workplace.

    Organisations are now utilising Moodbeam as a competitive advantage and have been viewed as investors in people when bidding for new business.

    34 min
  • Episode 2 - Dr Adam Kirk - CMO - My MHealth

    I'm excited to be joined today by my second special guest on the Domus Search Podcast, Dr Adam Kirk.

    Dr Adam is a Clinical Physician, Founder, Health & Medical Technology Entrepreneur/Innovator and exactly the person I would want to meet if I had a medical concern! 

    Adam gave me insights into medicine, his inspirations and mentors along the way, lessons learned and future plans.

    Dr Adam is Medical Director at my mhealth. You can find out more here www.mymhealth.com - my mhealth is a leader and an innovator in digital therapeutics. Co-Founder and Clinical Director at SpectroFlow Inc. A unique platform that allows patients a friendly med device to preclincally detect & help lessen the effects of lymphedema & CVI - find out more here - www.spectroflow.com. Scientific Board Advisor at Alio.ai, formerly Graftworx. Alio.ai are a wearable technology company enabling greater insights through clinical grade real-time data. You can find out more at www.alio.ai and Consultant Physician at Lymington  New Forest Hospital. 

    You can also connect with Dr Adam directly here - www.linkedin.com/in/adam-kirk-0083a054/

    It's fair to say that Dr Adam has his finger on the pulse on the current and future needs of not only his direct patients, but the global community who will, I have no doubt, benefit from his expertise, innovation, technology solutions and partnerships that he creates at any organisation he is involved in.

    I hope you enjoy the show.



    47 min
  • Episode 1 - Boda Gallon - CEO & Partner - Reability Online & Hervines Group
    An insightful conversation with visionary healthcare leader, Boda Gallon. Boda is an accomplished and award winning CEO and consultant across the global healthcare, social care and rehabilitation sectors. Boda is also a former elite athlete, Team GB Judo Squad Member and Commonwealth Champion. Having lived and studied in Japan, Boda shares is international experience with me on business, sport and leadership. To connect with Boda visit www.bodagallon.com where you will find links to his other social media channels. I hope you enjoy the show.
    54 min

About Domus Search - The European BioTech, Pharma & MedTech C-Suite Leadership Podcast

From the publisher's feed

Topical industry and executive career discussions with C-Suite leaders, KOLs and Subject Matter Experts in BioTech, Pharma and MedTech, Private Equity and Venture Capital organisations across the European Healthcare Ecosystems.